Cosmos Health (NASDAQ: COSM) CEO swaps $72K debt for stock in Form 4

Rhea-AI Filing Summary

Cosmos Health Inc. CEO Grigorios Siokas acquired 133,953 common shares at $0.5375 per share on January 6, 2026. The shares were issued under a Debt Exchange Agreement in which $72,000 of debt the company owed to Mr. Siokas was exchanged for stock at the fair market value of the common shares on that date.

After this transaction, Mr. Siokas beneficially owned 6,850,724 shares of Cosmos Health common stock in direct ownership. He is reported as a director, chief executive officer, and a 10% owner of the company.

Insider Trade Summary

Net Buyer: 133,953 shares ($72,000)

Net Buy 1 txn

Insider Siokas Grigorios

Role Chief Executive Officer

Bought 133,953 shs ($72K)

Type	Security	Shares	Price	Value
Purchase	Common Stock, par value $.001	133,953	$0.5375	$72K

Holdings After Transaction: Common Stock, par value $.001 — 6,850,724 shares (Direct)

Footnotes (1)

1. [object Object]

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 01/07/2026 - 01:01 PM Learn about SEC filing dates

FAQ

What insider transaction did Cosmos Health (COSM) report on this Form 4?

Cosmos Health reported that CEO, director, and 10% owner Grigorios Siokas acquired 133,953 shares of common stock on January 6, 2026.

At what price were the new Cosmos Health (COSM) shares acquired by the CEO?

The 133,953 shares of Cosmos Health common stock were acquired at $0.5375 per share, described as the fair market value on January 6, 2026.

Was the Cosmos Health CEO’s Form 4 transaction an open-market purchase?

No. The filing explains the shares are Exchange Shares issued under a Debt Exchange Agreement, where $72,000 of debt owed to Grigorios Siokas was exchanged for stock.

How many Cosmos Health (COSM) shares does Grigorios Siokas own after this transaction?

Following the reported transaction, Grigorios Siokas beneficially owned 6,850,724 shares of Cosmos Health common stock, held in direct ownership.

What is Grigorios Siokas’s role and relationship to Cosmos Health (COSM)?

Grigorios Siokas is listed as a director, Chief Executive Officer, and a 10% owner of Cosmos Health Inc. on this Form 4.

What does the Debt Exchange Agreement in the Cosmos Health Form 4 describe?

The Debt Exchange Agreement states that $72,000 of debt Cosmos Health owed to Grigorios Siokas was exchanged for Exchange Shares at $0.5375 per share, the fair market value of the common stock on January 6, 2026.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Siokas Grigorios

(Last) (First) (Middle)

5 AG. GEORGIOU STR

PILEA

(Street)

THESSALONIKI J3 TK57001

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Cosmos Health Inc. [ COSM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
01/06/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $.001	01/06/2026	01/06/2026	P(1)		133,953	A	$0.5375	6,850,724	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Pursuant to a debt exchange agreement by and between Grigorios Siokas, the Company's CEO and the Company (the "Debt Exchange Agreement"), dated as of January 6, 2026, these shares are Exchange Shares (as defined in the Debt Exchange Agreement) being acquired by Mr. Siokas at the Exchange Rate (as defined in the Debt Exchange Agreement) of $0.5375 per share, the fair market value of the Common Stock on January 6, 2026, in exchange for a total amount of $72,000 in debt the Company owed to Mr. Siokas.

Remarks:

	/s/ Grigorios Siokas	01/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.